CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 44.20% | 105.44% | 127.25% | 11.68% | 187.85% |
| Total Depreciation and Amortization | 0.56% | 0.40% | 0.93% | 1.14% | 2.56% |
| Total Amortization of Deferred Charges | -6.83% | -8.48% | -8.67% | -6.75% | 0.30% |
| Total Other Non-Cash Items | -31.55% | -114.59% | -62.15% | 117.63% | -88.80% |
| Change in Net Operating Assets | -61.32% | -0.37% | 84.71% | 88.27% | 80.59% |
| Cash from Operations | 13.31% | 33.20% | 213.88% | 371.29% | 442.36% |
| Capital Expenditure | 11.81% | 31.25% | 29.99% | 25.02% | 24.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 185.00% | -- | 100.00% | 100.00% | -- |
| Cash from Investing | 21.53% | 34.68% | 35.34% | 85.21% | 92.88% |
| Total Debt Issued | -14.23% | 8.53% | 19.24% | 32.31% | -41.57% |
| Total Debt Repaid | 10.35% | -5.51% | -24.93% | -59.47% | 11.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.49% | -0.61% | -0.72% | -0.86% | -1.54% |
| Other Financing Activities | -28.93% | -2,725.56% | -479.64% | -451.89% | 76.51% |
| Cash from Financing | -22.28% | -36.74% | -295.25% | -457.41% | -159.59% |
| Foreign Exchange rate Adjustments | -301.45% | -678.94% | -62.82% | -197.86% | -6.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.86% | 103.51% | 379.28% | 104.03% | 351.60% |